Results from wound healing assay (Fig. 14e) and transwell assay (Fig. 14d) indicated that the migration ability of BLCA cells was significantly affected by the RAP2C-AS1 inhibition. The gene discussed is RAP2C; the disease is bladder transitional cell carcinoma.